Cargando…

A novel PIBF1-RET gene fusion identified from a stage IA lung adenocarcinoma: A case report

Rearranged during transfection (RET) gene fusions occur in 0.7% to 2% in lung cancer and 1% to 2% in non-small cell lung cancer. Systemic therapies for RET fusion-positive non-small cell lung cancer consist mostly of targeted therapy with RET inhibitors such as selpercatinib and pralsetinib. To date...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhao, Weidi, Sun, Jia’en, Zhu, Huangkai, Zhao, Guofang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2023
Materias:	5700
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10662845/ https://www.ncbi.nlm.nih.gov/pubmed/37478265 http://dx.doi.org/10.1097/MD.0000000000034305

Ejemplares similares

Durable response to low-dose pralsetinib in a renal insufficient patient with NSCLC harboring concurrent CCDC6-RET, LINCO1264-RET, and SEMA5A-RET fusions: A case report
por: Gu, Linping, et al.
Publicado: (2022)

Predictive Value of (18)F-FDG PET and CT Morphologic Features for Recurrence in Pathological Stage IA Non-Small Cell Lung Cancer
por: Ko, Kai-Hsiung, et al.
Publicado: (2015)

Possible pathways used to predict different stages of lung adenocarcinoma
por: Chen, Xiaodong, et al.
Publicado: (2017)

Prognostic value of metabolic variables of [18F]FDG PET/CT in surgically resected stage I lung adenocarcinoma
por: Wang, Xiao-Yi, et al.
Publicado: (2017)

Concurrent Oncogene Mutation Profile in Chinese Patients With Stage Ib Lung Adenocarcinoma
por: Wen, Ying-Sheng, et al.
Publicado: (2014)

Research progress on the relationship between the TOR signaling pathway regulator, epigenetics, and tumor development
por: Sun, Jiaen, et al.
Publicado: (2022)

Molecular profiling identifies prognostic markers of stage IA lung adenocarcinoma
por: Zhang, Jie, et al.
Publicado: (2017)

Pulmonary function protection by single-port thoracoscopic segmental lung resection in elderly patients with IA non-small cell lung cancer: A differential matched analysis
por: Wang, Silin, et al.
Publicado: (2023)

Big data analysis identified a telomere-related signature predicting the prognosis and drug sensitivity in lung adenocarcinoma
por: Zhang, Weiyi
Publicado: (2023)

A rare double ALK fusion variant EML4-ALK and CDK15-ALK in lung adenocarcinoma and response to crizotinib: A case report
por: Guo, Jun, et al.
Publicado: (2020)

Correlations Between the EGFR Mutation Status and Clinicopathological Features of Clinical Stage I Lung Adenocarcinoma
por: Isaka, Tetsuya, et al.
Publicado: (2015)

Comparison of different automated lesion delineation methods for metabolic tumor volume of (18)F-FDG PET/CT in patients with stage I lung adenocarcinoma
por: Wang, Xiao-Yi, et al.
Publicado: (2017)

Prognosis-related autophagy genes in female lung adenocarcinoma
por: Liu, Zhongxiang, et al.
Publicado: (2022)

Small-Cell Lung Cancer Transformation in Patients With Pulmonary Adenocarcinoma: A Case Report and Review of Literature
por: Jiang, Shi-Yu, et al.
Publicado: (2016)

Weighted gene coexpression network analysis identifies hub genes related to KRAS mutant lung adenocarcinoma
por: Dai, Dongjun, et al.
Publicado: (2020)

Effective treatment in lung adenocarcinoma patient with brain metastases harboring novel CLHC1/RNT4 intergenic region- ALK fusion: A case report
por: Xia, Huanling, et al.
Publicado: (2022)

Initial Metastatic Site as a Prognostic Factor in Patients With Stage IV Pancreatic Ductal Adenocarcinoma
por: Kim, Hyoung Woo, et al.
Publicado: (2015)

Identification of triple gene fusion ALK-LRRN2, LTBP1-ALK, and HIP1-ALK in advanced lung adenocarcinoma and response to alectinib: A case report
por: Ning, Shangkun, et al.
Publicado: (2021)

A novel prognostic signature for lung adenocarcinoma based on cuproptosis-related lncRNAs: A Review
por: Di, Huang, et al.
Publicado: (2022)

XXYLT1 methylation contributes to the occurrence of lung adenocarcinoma: Methylation and lung adenocarcinoma
por: Zeng, Hui, et al.
Publicado: (2021)

Durable response to osimertinib in an advanced lung adenocarcinoma patient with an uncommon EGFR T854A mutation: A case report
por: Zhao, Nan, et al.
Publicado: (2022)

Clinicopathological, radiographic, and oncogenic features of primary pulmonary enteric adenocarcinoma in comparison with invasive adenocarcinoma in resection specimens
por: Zhao, Long, et al.
Publicado: (2017)

Multiple bioinformatics analysis identifies IGFBP1 as associated with the prognosis of stomach adenocarcinoma
por: Luo, Xiao-Ye, et al.
Publicado: (2023)

A rare survival case of blunt left ventricular rupture caused by a low-energy pedestrian collision with a stationary forklift: a case report
por: Zhu, Huangkai, et al.
Publicado: (2021)

Comparison of definitive chemoradiotherapy and radiotherapy alone in patients older than 75 years with locally advanced esophageal carcinoma: A retrospective cohort study
por: Zhao, Qian, et al.
Publicado: (2017)

Prognostic factors in patients with gallbladder adenocarcinoma identified using competing-risks analysis: A study of cases in the SEER database
por: Han, Didi, et al.
Publicado: (2020)

Lysosome-related genes: A new prognostic marker for lung adenocarcinoma
por: Hu, Zeyang, et al.
Publicado: (2023)

Urachal adenocarcinoma that metastasized to breast was misinterpreted as primary breast mucinous carcinoma: A rare case report and literature review
por: Zhao, Xiang-Rong, et al.
Publicado: (2016)

Construction of an m6A-related lncRNA model for predicting prognosis and immunotherapy in patients with lung adenocarcinoma
por: Shen, Hong-Yu, et al.
Publicado: (2023)

The prognostic effect of metastasis patterns on overall survival in organ metastatic lung adenocarcinoma
por: Tie, Xiaowei, et al.
Publicado: (2022)

S-1 plus apatinib as first-line palliative treatment for stage IVB gastroesophageal junction adenocarcinoma: A case report and review of the literature
por: Zhang, Chu, et al.
Publicado: (2020)

The Role of Extracellular Vesicles and PIBF in Embryo-Maternal Immune-Interactions
por: Szekeres-Bartho, Julia, et al.
Publicado: (2018)

Atrial fibrillation was changed into sinus bradycardia in a ROS1-positive advanced lung adenocarcinoma patient who achieved durable response to Crizotinib: A case report and literature review
por: Liu, Lan, et al.
Publicado: (2017)

C-terminal binding protein-2 is a prognostic marker for lung adenocarcinomas
por: Li, Binfeng, et al.
Publicado: (2020)

Development of fatty acid metabolism-related models in lung adenocarcinomaA Review
por: Ye, Wei, et al.
Publicado: (2023)

Identification of TLRs as potential prognostic biomarkers for lung adenocarcinoma
por: Ying, Junjie, et al.
Publicado: (2023)

Relative Low Glycometabolism May Also Occur in Invasive Lung Adenocarcinoma With Visceral Pleural Invasion: Case Report and Comments
por: Jiang, Chunyang, et al.
Publicado: (2014)

Lung adenocarcinoma with EGFR gene mutation metastatic to the uterine cervix: A case report
por: Wang, Yong, et al.
Publicado: (2020)

Breast metastasis from EGFR/ALK negative lung adenocarcinoma: A case report
por: Cao, Liyu, et al.
Publicado: (2020)

In silico analysis reveals PRR11 as a prognostic and oncogenic marker in lung adenocarcinoma
por: Hu, Ankang, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_pfdf24t3f3dhhahq1md4o8ds19